ACCESSION: MSBNK-SMB_Measured-HSA015P0204009
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 23
COMMENT: RAW_SPEC {'EL02_pos_10541': {'bp': 337455.0, 'sum': 746942.0}, 'EL02_pos_10437': {'bp': 320868.0, 'sum': 727813.0}, 'EL15_pos_10139': {'bp': 258309.0, 'sum': 661893.0}, 'EL20_pos_10106': {'bp': 214796.0, 'sum': 580709.0}, 'EL02_pos_10179': {'bp': 324766.0, 'sum': 803419.0}, 'EL21_pos_10115': {'bp': 242066.0, 'sum': 589097.0}, 'EL17_pos_10121': {'bp': 247881.0, 'sum': 690629.0}, 'EL08_pos_10348': {'bp': 197744.0, 'sum': 490194.0}, 'EL20_pos_10348': {'bp': 222990.0, 'sum': 565969.0}, 'EL21_pos_10367': {'bp': 258207.0, 'sum': 622458.0}, 'EL09_pos_10109': {'bp': 240112.0, 'sum': 578288.0}, 'EL09_pos_10354': {'bp': 225735.0, 'sum': 570745.0}, 'EL14_pos_10361': {'bp': 203033.0, 'sum': 516884.0}, 'EL14_pos_10108': {'bp': 186378.0, 'sum': 594471.0}, 'EL01_pos_10077': {'bp': 214513.0, 'sum': 588749.0}, 'EL18_pos_10426': {'bp': 181502.0, 'sum': 518328.0}, 'EL01_pos_10342': {'bp': 174834.0, 'sum': 497753.0}, 'EL08_pos_10100': {'bp': 212824.0, 'sum': 578968.0}, 'EL16_pos_10100': {'bp': 200911.0, 'sum': 548288.0}, 'EL01_pos_10426': {'bp': 169485.0, 'sum': 465598.0}, 'EL18_pos_10329': {'bp': 206988.0, 'sum': 552715.0}, 'EL14_pos_10457': {'bp': 203649.0, 'sum': 500653.0}, 'EL18_pos_10077': {'bp': 192044.0, 'sum': 570198.0}}
COMMENT: RETENTION_TIME_STDEV 0.246
COMMENT: PRECURSOR_M/Z_RAW 204.086892
COMMENT: PRECURSOR_M/Z_STDEV 0.000075
COMMENT: PRECURSOR_IN_MS1 mz 204.086669; int 53.113; delta(ppm) 1.063524
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.103; C8H13NO5; [M+H]+; delta(ppm) 0.103408
COMMENT: PROPOSED_MF MS-FINDER 3.390; C8H13NO5; [M+H]+; delta(ppm) 0.103074
COMMENT: PROPOSED_MF MS-FINDER 2.220; C9H17NS2; [M+H]+; delta(ppm) -4.154990
COMMENT: PROPOSED_MF SIRIUS5_Sirius 45.816; C8H13NO5; [M+H]+; delta(ppm) 0.103074
COMMENT: PROPOSED_MF SIRIUS5_Sirius 20.832; C9H9N5O; [M+H]+; delta(ppm) -6.450051
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C9H17NS2; [M+H]+; delta(ppm) -4.154990
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H13NO5; [M+H]+; delta(ppm) 0.103074
COMMENT: PROPOSED_MF SIRIUS6_Sirius 66.569; C8H13NO5; [M+H]+; delta(ppm) 0.103074
COMMENT: PROPOSED_MF SIRIUS6_Sirius 54.186; C6H11N4O4; [M+H]+; delta(ppm) 6.682008
COMMENT: PROPOSED_MF SIRIUS6_Sirius 42.751; C7H17NO2Si2; [M+H]+; delta(ppm) -238571.227738
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.846; C9H9N5O; [M+H]+; delta(ppm) -6.450051
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.877; C5H12N6OP; [M+H]+; delta(ppm) -7.964597
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.990; C8H17NOSSi; [M+H]+; delta(ppm) -238571.876518
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.354; C9H14FNOS; [M+H]+; delta(ppm) 6.764290
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.803; C4H9F4N5; [M+H]+; delta(ppm) -0.067403
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.790; C7H7N8; [M+H]+; delta(ppm) 0.128796
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.965; C9H17NS2; [M+H]+; delta(ppm) -4.154990
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H13NO5; [M+H]+; delta(ppm) 0.103074
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.498; ZZYBFRMUWNOGKV-UHFFFAOYSA-N; [M+H]+; N=C(OC)C=1OC(CO)C(O)C(O)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.492; LKFJQOCOGNNTCY-BWZBUEFSSA-N; [M+H]+; CC(=O)NC1=CO[C@H](CO)[C@@H](O)[C@@H]1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.428; VTIRMWCDXGHHAD-GTZZQALGNA-N; [M+H]+; O[C@H]1CCN2[C@H]1[C@@H](O)[C@H](O)[C@H]2C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.289; IWTQHHGDTGYBCY-UHFFFAOYNA-N; [M+H]+; COCC(=O)N1CC(O)CC1C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.148; GLIQJUYGTGNRDD-UHFFFAOYNA-N; [M+H]+; CCOC(=O)N1CC(O)CC1C(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.548; LKFJQOCOGNNTCY-BWZBUEFSSA-N; [M+H]+; 2-acetamidoglucal
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.507; VTIRMWCDXGHHAD-GTZZQALGNA-N; [M+H]+; 7a-Epialexaflorine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.462; BYJOXMZXXVYXJJ-GJMOJQLCSA-N; [M+H]+; 3-amino-4,5,6-trihydroxy-2-methoxy-5-methyl-2-cyclohexen-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.425; IWTQHHGDTGYBCY-UHFFFAOYNA-N; [M+H]+; N-(methoxyacetyl)-4-hydroxyproline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.362; ZZYBFRMUWNOGKV-UHFFFAOYSA-N; [M+H]+; methyl 3,4-dihydroxy-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-6-carboximidate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.301; GLIQJUYGTGNRDD-UHFFFAOYNA-N; [M+H]+; N-(ethoxycarbonyl)-4-hydroxyproline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.678; LDIRGNDMTOGVRB-UHFFFAOYSA-N; [M+H]+; 1-Isothiocyanato-7-(methylthio)heptane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZZYBFRMUWNOGKV-UHFFFAOYSA-N; [M+H]+; methyl 3,4-dihydroxy-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-6-carboximidate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.953; LKFJQOCOGNNTCY-BWZBUEFSSA-N; [M+H]+; 2-acetamidoglucal
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.927; VTIRMWCDXGHHAD-GTZZQALGNA-N; [M+H]+; 7a-Epialexaflorine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.828; IWTQHHGDTGYBCY-UHFFFAOYNA-N; [M+H]+; N-(methoxyacetyl)-4-hydroxyproline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.783; GLIQJUYGTGNRDD-UHFFFAOYNA-N; [M+H]+; N-(ethoxycarbonyl)-4-hydroxyproline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.686; BYJOXMZXXVYXJJ-GJMOJQLCSA-N; [M+H]+; 3-amino-4,5,6-trihydroxy-2-methoxy-5-methyl-2-cyclohexen-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.906; LKFJQOCOGNNTCY-BWZBUEFSSA-N; [M+H]+; N-[(2R,3S,4R)-3,4-dihydroxy-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-5-yl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.793; PFLHGSJLYNJIOF-UHFFFAOYSA-N; [M+H]+; diethyl 2-formamidopropanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; OERNBXIJUQXVTQ-UHFFFAOYSA-N; [M+H]+; 2-[2-(prop-2-enoxycarbonylamino)ethoxy]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.470; UJHDYVYBNDNRRQ-UHFFFAOYSA-N; [M+H]+; 6-(carboxymethylamino)-6-oxohexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.446; ARHDVFIZXUIWIH-UHFFFAOYSA-N; [M+H]+; 5-[(2-methoxy-2-oxoethyl)amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.355; VRPXVQSXUIFMKQ-LURJTMIESA-N; [M+H]+; dimethyl (2S)-2-acetamidobutanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.338; AKENSLPCKUWJFX-YFKPBYRVSA-N; [M+H]+; (2S)-2-(butanoylamino)butanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.302; YMXLCHWGCXJOTL-UHFFFAOYSA-N; [M+H]+; methyl 3-[(3-methoxy-3-oxopropyl)amino]-3-oxopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -81.798; GKTCYHZKYCPMGF; [M+H]+; N-[(3S,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3,4,5,6-tetrahydro-2H-pyran-2-ylium-3-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.322; PJFUEEUSPVNDFW; [M+H]+; N-[(1R,2S,3R,4R,5R)-2,3-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-4-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.450; LKFJQOCOGNNTCY; [M+H]+; 2-Acetamidoglucal
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.251; PDBSWNMXMILYCQ; [M+H]+; 5-(hydroxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]oxazole-6,7-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.824; PFWSBQDWGJPSQD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.198; FTTGAAZKBNZDCZ; [M+H]+; N2-Acetyl-L-aminoadipate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.268; AKENSLPCKUWJFX; [M+H]+; n-butanoyl-l-aspartic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.493; SKDZKSPLPOVPAQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.244; ZZYBFRMUWNOGKV; [M+H]+; Methyl 2,6-anhydro-3-deoxy-D-lyxo-hept-2-enonimidate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.973; BQIWMXJSUKQGQR; [M+H]+; N-[(2R,3R)-3,4-dihydroxy-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-5-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -294.279; GOSRYDNGTVDLKK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.604; VTLRWWOCHQTVLL; [M+H]+; Dimethyl 2-amino-3-oxoadipate HCl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.918; PFLHGSJLYNJIOF; [M+H]+; Diethyl formamidomalonate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -323.103; KIPYNMRUUNEIEA; [M+H]+; 2-(2-Carboxy-3-methoxymethylcyclopropyl)glycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -350.362; IWTQHHGDTGYBCY; [M+H]+; 4-hydroxy-1-(methoxyacetyl)proline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.007; GLIQJUYGTGNRDD; [M+H]+; 1-(ethoxycarbonyl)-4-hydroxyproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -385.917; VTIRMWCDXGHHAD; [M+H]+; 1,2,7-trihydroxy-2,3,5,6,7,8-hexahydro-1H-pyrrolizine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -410.030; XWZPJRNVELUELY; [M+H]+; 2,3-Dihydroxypropyl 5-oxo-L-prolinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -411.331; UUIBNQLYUYNUOZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -411.337; BYJOXMZXXVYXJJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -443.632; VWTJOUUXTYKUIB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -451.649; IZJMYWFXWVNTSR; [M+H]+; 2,4-Dftpg
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.771; GKTCYHZKYCPMGF; [M+H]+; N-[(3S,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3,4,5,6-tetrahydro-2H-pyran-2-ylium-3-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.206; GKTCYHZKYCPMGF; [M+H]+; N-[(3S,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3,4,5,6-tetrahydro-2H-pyran-2-ylium-3-yl]acetamide;hydron
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.788; PJFUEEUSPVNDFW; [M+H]+; N-[(1R,2S,3R,4R,5S)-2,3-dihydroxy-6,8-dioxabicyclo[3.2.1]octan-4-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.408; PDBSWNMXMILYCQ; [M+H]+; 1,2-[Oxy(methylmethylidynenitrilo)]-1,2-dideoxy-D-glucopyranose
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.459; OQICBGAPWHDCIO; [M+H]+; (4aS,7R,8R,8aR)-7-(hydroxymethyl)-3-methyl-5,7,8,8a-tetrahydro-4aH-pyrano[3,4-e][1,2,4]dioxazin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -200.078; GOSRYDNGTVDLKK; [M+H]+; (5S,6R,7S,8R)-8-(hydroxymethyl)-3-methyl-2-oxa-1-oxonia-4-azabicyclo[3.3.1]non-3-ene-6,7-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -243.816; SKDZKSPLPOVPAQ; [M+H]+; (4aR,5R,7S,8aS)-7-(hydroxymethyl)-3-methyl-5,7,8,8a-tetrahydro-4aH-pyrano[3,4-e][1,2,4]dioxazin-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.073; PFWSBQDWGJPSQD; [M+H]+; N-[(3S,4R,6R)-4-hydroxy-6-(hydroxymethyl)-5-oxooxan-3-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -280.436; ZZYBFRMUWNOGKV; [M+H]+; methyl 3,4-dihydroxy-2-(hydroxymethyl)-3,4-dihydro-2H-pyran-6-carboximidate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -296.500; PFLHGSJLYNJIOF; [M+H]+; Diethyl formamidomalonate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -303.390; FTTGAAZKBNZDCZ; [M+H]+; N-Acetyl-L-2-Aminoadipic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.738; GKTCYHZKYCPMGF; [M+H]+; N-[(3S,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3,4,5,6-tetrahydro-2H-pyran-2-ylium-3-yl]acetamide;hydron
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C8H14N1O5; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.709
MS$FOCUSED_ION: PRECURSOR_M/Z 204.086670
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-2690000000-659c3e7713e6727f045a
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  57.0701016 19.7398 57.070818 1.0864 7.47 0.5143 21 f{C4H9}/3.94ppm,p-C4H5N1O5
  60.0446116 21.8563 60.045339 1.2657 8.29 0.6532 23 f{C2H6N1O1}/3.69ppm,p-C6H8O4
  72.9372511 89.3581 72.937994 0.8089 22.96 -0.6156 23 ?
  84.0444340 63.0947 84.045150 1.0352 25.42 1.0000 23 f{C4H6N1O1}/0.52ppm,p-C4H8O4
  90.9476433 15.8178 90.948324 1.4074 5.04 0.0456 19 ?
  96.0444039 33.9016 96.045049 0.8329 16.71 0.7572 22 f{C5H6N1O1}/0.14ppm,p-C3H8O4
  97.0282862 12.9079 97.028924 1.2161 5.51 0.8877 19 f{C5H5O2}/-1.23ppm,p-C3H9N1O3
  98.0600614 29.6834 98.060691 1.2849 12.41 0.8045 20 f{C5H8N1O1}/0.22ppm,p-C3H6O4
  113.9637232 262.5693 113.964215 0.5177 74.75 -0.6957 23 ?
  119.0855755 11.4563 119.086023 2.0070 2.66 0.0279 18 ?
  126.0550062 68.2424 126.055385 0.8806 25.42 0.7737 23 f{C6H8N1O2}/0.41ppm,p-C2H6O3
  131.9743315 87.5550 131.974643 0.8259 22.11 -0.6403 23 ?
  138.0549286 55.3624 138.055197 1.0938 22.93 0.8310 23 f{C7H8N1O2}/-0.19ppm,p-C1H6O3
  144.0655701 56.8293 144.065855 1.2703 19.85 0.7372 23 f{C6H10N1O3}/0.35ppm,p-C2H4O2
  154.9903014 51.7073 154.990616 1.2517 17.25 -0.6702 19 ?
  188.1069225 88.8382 188.107334 0.9729 8.59 0.0853 22 ?
  189.1147753 158.0551 189.115190 0.7667 12.35 0.1522 23 ?
  204.1382922 999.0000 204.138733 0.3380 0.00 0.1650 23 ?
  205.1416128 125.8004 205.142051 0.8482 10.62 0.1976 23 ?
PK$NUM_PEAK: 19
PK$PEAK: m/z int. rel.int.
  57.070102 19.74 19
  60.044612 21.86 21
  72.937251 89.36 89
  84.044434 63.09 63
  90.947643 15.82 15
  96.044404 33.90 33
  97.028286 12.91 12
  98.060061 29.68 29
  113.963723 262.57 262
  119.085575 11.46 11
  126.055006 68.24 68
  131.974332 87.56 87
  138.054929 55.36 55
  144.065570 56.83 56
  154.990301 51.71 51
  188.106923 88.84 88
  189.114775 158.06 158
  204.138292 999.00 999
  205.141613 125.80 125
//
